| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking (NCT00790569) | Butler Hospital | 2008-09-01 |
| Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder (NCT00694915) | Cadila Pharnmaceuticals | 2008-08-28 |
| Quality of Life in Patients With Bladder Cancer (NCT00745355) | Memorial Sloan Kettering Cancer Center | 2008-08-01 |
| Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma (NCT00867620) | National Taiwan University Hospital | 2008-08-01 |
| Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium (NCT00756639) | M.D. Anderson Cancer Center | 2008-07-21 |
| Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma (NCT00714948) | Memorial Sloan Kettering Cancer Center | 2008-07-01 |
| Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder (NCT00722553) | Acrotech Biopharma Inc. | 2008-07-01 |
| A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer (NCT00661609) | AstraZeneca | 2008-05-01 |
| Health-Related Quality of Life in Patients With Bladder Cancer (NCT00744744) | David Latini | 2008-05-01 |
| Quality of Life and Symptom Management in Patients With Bladder Cancer (NCT00772018) | David Latini | 2008-05-01 |
| The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients (NCT00859768) | Netherlands Open University | 2008-04-01 |
| SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial (NCT00578526) | AHS Cancer Control Alberta | 2008-04-01 |
| Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer (NCT00645593) | University of Michigan Rogel Cancer Center | 2008-03-01 |
| Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer (NCT00633204) | Iwate Medical University | 2008-02-01 |
| Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom (NCT00757614) | Cancer Research UK | 2008-02-01 |
| Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium (NCT01090466) | Cardiff University | 2008-02-01 |
| Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer (NCT00635726) | Hellenic Oncology Research Group | 2008-02-01 |
| Pilot Studie of Lipiodol Demarcation of the Tumour in Bladder Cancer (NCT00609843) | University of Aarhus | 2008-02-01 |
| Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer (NCT00634621) | GE Healthcare | 2008-02-01 |
| Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent (NCT00544609) | Spanish Oncology Genito-Urinary Group | 2007-12-01 |
| Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer (NCT00585689) | University of Michigan Rogel Cancer Center | 2007-12-01 |
| Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum (NCT01426126) | Asan Medical Center | 2007-12-01 |
| Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors (NCT00567684) | M.D. Anderson Cancer Center | 2007-11-15 |
| Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer (NCT00623064) | European Organisation for Research and Treatment of Cancer - EORTC | 2007-11-01 |
| Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder (NCT00963859) | M.D. Anderson Cancer Center | 2007-10-01 |
| Sunitinib in Treating Patients With Locally Advanced Bladder Cancer (NCT00526656) | Case Comprehensive Cancer Center | 2007-09-01 |
| USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases (NCT00622973) | Insel Gruppe AG, University Hospital Bern | 2007-09-01 |
| S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer (NCT00445601) | SWOG Cancer Research Network | 2007-09-01 |
| Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) (NCT00598806) | Spectrum Pharmaceuticals, Inc | 2007-08-01 |
| Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (NCT00516750) | Kyoto University | 2007-07-01 |
| Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer (NCT00867347) | Institute of Cancer Research, United Kingdom | 2007-07-01 |
| Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia (NCT00491296) | HaEmek Medical Center, Israel | 2007-06-01 |
| Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer (NCT00506155) | M.D. Anderson Cancer Center | 2007-06-01 |
| Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer (NCT01801644) | Barmherzige Brüder Vienna | 2007-04-01 |
| A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors (NCT00465725) | Poniard Pharmaceuticals | 2007-04-01 |
| Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) (NCT00461591) | Spectrum Pharmaceuticals, Inc | 2007-04-01 |
| Screening for Bladder Cancer (NCT00848627) | Baylor College of Medicine | 2007-03-01 |
| Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma (NCT00461851) | Yale University | 2007-03-01 |
| Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ (NCT00462488) | Sesen Bio, Inc. | 2007-03-01 |
| First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy (NCT00389155) | Bristol-Myers Squibb | 2007-01-01 |
| In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? (NCT03174912) | Ankara Training and Research Hospital | 2007-01-01 |
| S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin (NCT00234039) | SWOG Cancer Research Network | 2006-11-01 |
| Sorafenib in Urothelium Cancer of Bladder (NCT01215266) | Association of Urologic Oncology (AUO) | 2006-10-01 |
| Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium (NCT00397488) | Memorial Sloan Kettering Cancer Center | 2006-09-01 |
| The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer (NCT01697306) | A.O.U. Città della Salute e della Scienza | 2006-09-01 |
| Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC (NCT00880334) | Dana-Farber Cancer Institute | 2006-09-01 |
| Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer (NCT01118039) | Hospital del Mar | 2006-07-01 |
| Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants (NCT00900276) | Wake Forest University Health Sciences | 2006-06-01 |
| Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer (NCT01824329) | University of Michigan | 2006-06-01 |
| Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma (NCT00393796) | University of Michigan Rogel Cancer Center | 2006-05-01 |
| Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer (NCT00380029) | UNC Lineberger Comprehensive Cancer Center | 2006-05-01 |
| Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer (NCT00318643) | Halozyme Therapeutics | 2006-03-30 |
| Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors (NCT00335491) | University of Utah | 2006-03-01 |
| Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking (NCT00365508) | Fox Chase Cancer Center | 2006-02-01 |
| Eingeschränkte vs Ausgedehnte Lymphadenektomie LEA (NCT01215071) | Association of Urologic Oncology (AUO) | 2006-02-01 |
| Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00313599) | University of California, San Francisco | 2006-02-01 |
| Bupropion in Helping Adults Stop Smoking (NCT00534001) | Roswell Park Cancer Institute | 2006-01-01 |
| Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer (NCT00648102) | Celldex Therapeutics | 2006-01-01 |
| NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers. (NCT00318266) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2006-01-01 |
| Quality of Life in Patients With Bladder Cancer (NCT00553215) | University of Birmingham | 2005-12-01 |
| Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer (NCT00553345) | University of Birmingham | 2005-12-01 |
| Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer (NCT00234494) | Christopher Sweeney, MBBS | 2005-11-01 |
| Identifying Methylation Biomarkers for Monitoring Bladder Tumors (NCT00244205) | Copenhagen University Hospital at Herlev | 2005-11-01 |
| Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy (NCT00350688) | Ottawa Hospital Research Institute | 2005-11-01 |
| Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer (NCT00237575) | University of Kentucky | 2005-11-01 |
| Cone Beam Computed Tomography (CT) Bladder (NCT00913536) | University Health Network, Toronto | 2005-11-01 |
| Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery (NCT00268450) | Medical University of South Carolina | 2005-09-21 |
| Survivin Urine mRNA Assay Risk of Bladder Cancer Study (NCT00315653) | Fujirebio Diagnostics, Inc. | 2005-09-01 |
| A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment (NCT00421889) | Valerio Therapeutics | 2005-08-01 |
| Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection (NCT00303654) | Roei Medical Technologies Ltd. | 2005-08-01 |
| Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract (NCT00315237) | Pierre Fabre Medicament | 2005-07-01 |
| A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast (NCT00147238) | M.D. Anderson Cancer Center | 2005-07-01 |
| Use of Multiphoton Microscopy in the Diagnosis of Cancer (NCT00652210) | Weill Medical College of Cornell University | 2005-06-01 |
| Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer (NCT00556621) | Institut du Cancer de Montpellier - Val d'Aurelle | 2005-06-01 |
| Markers of Response to Intravesical Bladder Cancer Therapy (NCT01007058) | M.D. Anderson Cancer Center | 2005-06-01 |
| A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer (NCT00412971) | Photocure | 2005-04-01 |
| Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy (NCT02345473) | Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | 2005-01-01 |
| Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy (NCT00233402) | Photocure | 2005-01-01 |
| Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium (NCT00101608) | Bristol-Myers Squibb | 2005-01-01 |
| Study of D-Methadone in Patients With Chronic Pain (NCT00588640) | Memorial Sloan Kettering Cancer Center | 2004-10-01 |
| NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine (NCT00199849) | Ludwig Institute for Cancer Research | 2004-09-27 |
| Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium (NCT00053209) | Eastern Cooperative Oncology Group | 2004-08-10 |
| Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer (NCT00095589) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-08-01 |
| Gemcitabine With Or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Bladder Cancer (NCT00627432) | Institut du Cancer de Montpellier - Val d'Aurelle | 2004-07-01 |
| Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases (NCT00587964) | Memorial Sloan Kettering Cancer Center | 2004-06-01 |
| S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium (NCT00087295) | SWOG Cancer Research Network | 2004-06-01 |
| URO-BCG-4 : Bladder Tumors Immunotherapy (NCT00213655) | University Hospital, Rouen | 2004-06-01 |
| Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging (NCT00612326) | Memorial Sloan Kettering Cancer Center | 2004-06-01 |
| Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer (NCT00088946) | Jonsson Comprehensive Cancer Center | 2004-05-01 |
| Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder (NCT00084578) | Fox Chase Cancer Center | 2004-03-01 |
| Internet-based System for Cancer Patients to Self-report Toxicity (NCT00578006) | Memorial Sloan Kettering Cancer Center | 2004-03-01 |
| Combination Chemotherapy in Treating Patients With Bladder Cancer (NCT00014534) | Alliance for Clinical Trials in Oncology | 2004-03-01 |
| A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) (NCT00709462) | Celldex Therapeutics | 2004-03-01 |
| Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer (NCT00582387) | Memorial Sloan Kettering Cancer Center | 2004-03-01 |
| Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer (NCT00696579) | University Of Perugia | 2004-01-01 |
| Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer (NCT00186277) | Stanford University | 2003-12-01 |
| Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium (NCT00082719) | M.D. Anderson Cancer Center | 2003-12-01 |
| Zinc Supplements in Lowering Cadmium Levels in Smokers (NCT00376987) | Wake Forest University Health Sciences | 2003-12-01 |
| Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer (NCT00490880) | Eli Lilly and Company | 2003-11-01 |
| Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors (NCT00216814) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2003-10-01 |